R1 RCM and Palantir Technologies are partnering to launch R37, an advanced artificial intelligence lab dedicated to "revolutionizing healthcare financial performance." ...

R1, an industry leader in revenue cycle management (“RCM”) with over 20 years of experience, and Palantir Technologies (NASDAQ:PLTR), a leader in arti ...

The firm has been selling off assets, presumably to help fund its Lincoln Yards project, which has failed to attract ...

R1 and Palantir Technologies Inc (NASDAQ: PLTR) have partnered to create R37, an AI lab aimed at revolutionizing healthcare ...

In this article, we are going to take a look at where R1 RCM Inc. (NASDAQ:RCM) stands against the other AI stocks. Investors have been desperately searching for a safer way to play the AI boom ...

R1 RCM (NASDAQ:RCM) agreed to be sold to TowerBrook and Clayton, Dubilier & Rice in a deal valued at $8.9 billion. R1 RCM ...

William Blair analysts issued a cautionary note on Palantir Technologies (NASDAQ:PLTR), highlighting potential downside risk for the stock despite continued commercial momentum.

Over the last year, R1 Rcm share price has been traded in a range of 3.73, hitting a high of 14.31, and a low of 10.58. R1 Rcm is listed on the CBOE trading with ticker code RCM.US.

MURRAY, Utah, Feb. 05, 2025 (GLOBE NEWSWIRE) -- R1 RCM Inc. ("R1”), a leader in technology-driven healthcare solutions, has been named a 2025 'Best in KLAS' award winner in several key categories, ...